GOLDEN THROAT HOLDINGS GROUP COMPANY LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.69 HKD | -1.60% |
|
-2.12% | +10.15% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Golden Throat Holdings Group Company Limited is principally engaged in the manufacture and sales of pharmaceutical, healthcare food and other products. The Companyâs flagship product is Golden Throat Lozenges (OTC), which is a type of lozenge mainly designed to relieve symptoms of sore, dry throat and hoarse voice caused by acute pharyngitis. The Company's subsidiaries include Golden Throat Industrial Holdings Limited, Guangxi Golden Throat Investment Consulting Co., Ltd. and Guangxi Golden Throat Co., Ltd..
Sector
Pharmaceuticals
Calendar
2024-08-21
- Q2 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| +10.15% | 354M | |
| +20.91% | 43.54B | |
| +16.96% | 21.74B | |
| +9.05% | 13.53B | |
| +7.98% | 13.02B | |
| +33.80% | 11.28B | |
| -11.05% | 6.99B | |
| -0.05% | 6.79B | |
| -8.87% | 5.73B | |
| +6.64% | 5.09B |
- Stock Market
- Equities
- 6896 Stock
- News Golden Throat Holdings Group Company Limited
- Golden Throat : Appoints Financial Adviser for Affirma Capital's Go-Private Bid
